Edition: Australia  
One News Page
“Probably the fastest-access news portal in the world”
> >

Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy

Reuters Tuesday, 14 November 2017 ()
SEOUL (Reuters) - A unit of healthcare conglomerate Johnson & Johnson has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug Remicade produced by South Korea's Samsung Bioepis Co Ltd from being sold in the United States.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Other recent news in Health

BUDGET blankLONDON's first Aids ward
Single cancer waiting times TARGET set for NHS WalesRITA ORA's egg freezing in early 20s 'a positive move,' doctors say
Public transit in TORONTO dangerously noisy, study saysTeva Pharmaceutical set for major layoffs in ISRAEL, U.S.: report
GERMANY reports outbreak of mild bird flu on farm: OIE

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+